Patents by Inventor Charles M. Hall
Charles M. Hall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 5320700Abstract: A high temperature film wrapping is used to wrap thermoplastic materials before they are molded. The thermoplastic material can then be molded by applying heat and pressure and the resulting thermoplastic material will contain reduced cracks and voids compared with thermoplastic materials molded without the wrapping.Type: GrantFiled: April 15, 1991Date of Patent: June 14, 1994Assignee: Phillips Petroleum CompanyInventors: Charles M. Hall, Wen W. Tseng, Ralph Beavers
-
Patent number: 4423223Abstract: Novel compounds of the formula ##STR1## wherein X and Y are the same or different and are hydrogen, fluora, chloro, bromo, alkyl of one to six carbon atoms, inclusive, alkoxy of one to six carbon atoms, inclusive, nitro, cyano, amino, trifluoromethyl, ##STR2## wherein R.sub.1 is alkyl of one to six carbon atoms, inclusive, ##STR3## wherein R.sub.2 and R.sub.3 are the same or different and are hydrogen or alkyl of one to three carbon atoms inclusive, or CO.sub.2 Q where Q is alkyl of one to six carbon atoms, inclusive, hydrogen or a physiologically acceptable metal or amine cation; and R is hydrogen, alkyl of one to eight carbon atoms, inclusive, --CH.sub.2).sub.m phenyl wherein m is 0, 1 or 2 or (CH.sub.2).sub.n NR.sub.4 R.sub.5 wherein n is 1 or 2, and R.sub.4 and R.sub.Type: GrantFiled: June 2, 1980Date of Patent: December 27, 1983Assignee: The Upjohn CompanyInventors: Charles M. Hall, John B. Wright
-
Patent number: 4281151Abstract: Compounds represented below ##STR1## and pharmaceutical compositions thereof, the compositions including the non-substituted phenylene dioxamates are useful in the prophylactic treatment of sensitized mammals for allergy and all anaphylactic reactions of a reagin or non-reagin mediated nature.Type: GrantFiled: June 2, 1978Date of Patent: July 28, 1981Assignee: The Upjohn CompanyInventors: Charles M. Hall, John B. Wright
-
Patent number: 4279930Abstract: A process for treating inflammation locally or topically by administering a compound of the formula: ##STR1## wherein M and M' are hydrogen, hydroxy, halogen, lower alkyl of from 1 to 3 carbon atoms, lower alkoxy of from 1 to 3 carbon atoms; NH.sub.2, RNH, R'.sub.2 N where R is lower alkyl of from 1 to 3 carbon atoms or lower acyl of from 1 to 3 carbon atoms and R' is lower alkyl of from 1 to 3 carbon atoms; X, Y and Z are hydrogen, hydroxy, halogen, lower alkoxy of from 1 to 3 carbon atoms or lower acyloxy of from 1 to 6 carbon atoms, in association with appropriate pharmaceutical carriers.Type: GrantFiled: September 14, 1979Date of Patent: July 21, 1981Assignee: The Upjohn CompanyInventors: Charles M. Hall, Eldridge M. Glenn
-
Patent number: 4262123Abstract: Compounds of the formula below are useful for expanding the lumina of air passages in a mammal in need of said treatment. The compounds are also useful for treating atopic eczema and urticaria. ##STR1## wherein X and Y are the same or different and are hydrogen, fluoro, chloro, bromo, nitro, trifluoromethyl, alkyl of one to four carbon atoms, inclusive, alkoxy of one to four carbon atoms, inclusive, and cyano;R.sub.1 is hydrogen, methyl or ethyl;R.sub.2 is hydrogen, alkyl of one to six carbon atoms, inclusive, phenyl, benzyl,CH.sub.2 Z wherein Z is fluoro, chloro, or bromo,CO.sub.2 M, CH.sub.2 CO.sub.2 M, CH.sub.2 CH.sub.2 CO.sub.2 M and CHR.sub.3 CO.sub.2 M wherein M is hydrogen, alkyl of one to four carbon atoms, inclusive, or a physiologically acceptable metal or amine cation and R is alkyl of one to three carbon atoms, inclusive, with the proviso that M is not hydrogen when R.sub.2 is CH.sub.2 CO.sub.2 M or CHR.sub.3 CO.sub.2 M.Type: GrantFiled: May 31, 1979Date of Patent: April 14, 1981Assignee: The Upjohn CompanyInventors: Charles M. Hall, Herbert G. Johnson
-
Patent number: 4242342Abstract: Compounds of the formula below are useful for expanding the lumina of air passages in a mammal in need of said treatment. The compounds are also useful for treating atopic eczema and urticaria. ##STR1## wherein X and Y are the same or different and are hydrogen, fluoro, chloro, bromo, nitro, trifluoromethyl, alkyl of one to four carbon atoms, inclusive, alkoxy of one to four carbon atoms, inclusive, and cyano;R.sub.1 is hydrogen, methyl or ethyl;R.sub.2 is hydrogen, alkyl of one to six carbon atoms, inclusive, phenyl, benzyl,CH.sub.2 Z wherein Z is fluoro, chloro, or bromo,CO.sub.2 M, CH.sub.2 CO.sub.2 M, CH.sub.2 CH.sub.2 CO.sub.2 M and CHR.sub.3 CO.sub.2 M wherein M is hydrogen, alkyl of one to four carbon atoms, inclusive, or a physiologically acceptable metal or amine cation and R.sub.3 is alkyl of one to three carbon atoms, inclusive, with the proviso that M is not hydrogen when R.sub.2 is CH.sub.2 CO.sub.2 M or CHR.sub.3 CO.sub.2 M.Type: GrantFiled: May 31, 1979Date of Patent: December 30, 1980Assignee: The Upjohn CompanyInventors: Charles M. Hall, Herbert G. Johnson
-
Patent number: 4186127Abstract: Compounds represented below ##STR1## and pharmaceutical compositions thereof, the compositions including the non-substituted phenylene dioxamates are useful in the prophylactic treatment of sensitized mammals for allergy and all anaphylactic reactions of a reagin or non-reagin mediated nature.Type: GrantFiled: July 27, 1977Date of Patent: January 29, 1980Assignee: The Upjohn CompanyInventors: Charles M. Hall, John B. Wright
-
Patent number: 4181724Abstract: Compounds of the formula below are useful for expanding the lumina or air passages in a mammal in need of said treatment. The compounds are also useful for treating atopic eczema and urticaria. ##STR1## wherein X and Y are the same or different and are hydrogen, fluoro, chloro, bromo, nitro, trifluoromethyl, alkyl of one to four carbon atoms, inclusive, alkoxy of one to four carbon atoms, inclusive, and cyano;R.sub.1 is hydrogen, methyl or ethyl;R.sub.2 is hydrogen, alkyl of one to six carbon atoms, inclusive, phenyl, benzyl,CH.sub.2 Z wherein Z is fluoro, chloro, or bromo,CO.sub.2 M, CH.sub.2 CO.sub.2 M, CH.sub.2 CH.sub.2 CO.sub.2 M and CHR.sub.3 CO.sub.2 M wherein M is hydrogen, alkyl of one to four carbon atoms, inclusive, or a physiologically acceptable metal or amine cation and R.sub.3 is alkyl of one to three carbon atoms, inclusive, with the proviso that M is not hydrogen when R.sub.2 is CH.sub.2 CO.sub.2 M or a CHR.sub.3 CO.sub.2 M.Type: GrantFiled: September 11, 1978Date of Patent: January 1, 1980Assignee: The Upjohn CompanyInventors: Charles M. Hall, Herbert G. Johnson
-
Patent number: 4172147Abstract: Novel compounds of the formula ##STR1## wherein R is alkyl of one to eight carbon atoms, inclusive, are formulated into pharmaceutical compositions suitable for oral or parenteral administration which are used as agents to prophylactically inhibit the allergic manifestations of a sensitized mammal.Type: GrantFiled: November 17, 1976Date of Patent: October 23, 1979Assignee: The Upjohn CompanyInventors: Charles M. Hall, John B. Wright
-
Patent number: 4159278Abstract: Compounds represented below ##STR1## and pharmaceutical compositions thereof, the compositions including the non-substituted phenylene dioxamates are useful in the prophylactic treatment of sensitized mammals for allergy and all anaphylactic reactions of a reagin or non-reagin mediated nature.Type: GrantFiled: October 31, 1977Date of Patent: June 26, 1979Assignee: The Upjohn CompanyInventors: Charles M. Hall, John B. Wright
-
Patent number: 4159341Abstract: A method of treating mammals for allergy and anaphylactic reactions of a reagin or non-reagin mediated nature which comprises administering prophylactically to said mammal an anti-allergy or anaphylactic reaction effective amount of a compound of the formula ##STR1## Novel compositions are also claimed.Type: GrantFiled: October 6, 1977Date of Patent: June 26, 1979Assignee: The Upjohn CompanyInventors: Charles M. Hall, John B. Wright
-
Patent number: 4156012Abstract: A method of treating mammals for allergy and anaphylactic reactions of a reagin or non-reagin mediated nature which comprises administering prophylactically to said mammal an anti-allergy or anaphylactic reaction effective amount of a compound of the formula ##STR1## Novel compositions are also claimed.Type: GrantFiled: October 6, 1977Date of Patent: May 22, 1979Assignee: The Upjohn CompanyInventors: Charles M. Hall, John B. Wright
-
Patent number: 4150140Abstract: Compounds of the formula ##STR1## wherein X and Y are the same or different and are hydrogen, fluoro, chloro, bromo, alkyl of one to six carbon atoms, inclusive, alkoxy of one to six carbon atoms, inclusive, nitro, cyano, amino, trifluoromethyl, ##STR2## wherein R.sub.1 is alkyl of one to six carbon atoms, inclusive, ##STR3## wherein R.sub.2 and R.sub.3 are the same or different and are hydrogen or alkyl of one to three carbon atoms inclusive, or CO.sub.2 Q where Q is alkyl of one to six carbon atoms, inclusive, hydrogen or a physiologically acceptable metal or amine cation; andR is hydrogen, alkyl of one to eight carbon atoms, inclusive, --CH.sub.2).sub.m phenyl wherein m is 0, 1 or 2 or (CH.sub.2).sub.n NR.sub.4 R.sub.5 wherein n is 1 or 2, and R.sub.4 and R.sub.Type: GrantFiled: December 23, 1976Date of Patent: April 17, 1979Assignee: The Upjohn CompanyInventors: Charles M. Hall, John B. Wright
-
Patent number: 4128660Abstract: Pharmaceutical composition having as the active agent a compound of the formula ##STR1## wherein R is hydrogen, a physiologically acceptable metal or amine cation and alkyl of one to eight carbon atoms inclusive, useful for preventing allergic manifestations in sensitized mammals.Type: GrantFiled: November 19, 1976Date of Patent: December 5, 1978Assignee: The Upjohn CompanyInventors: Charles M. Hall, John B. Wright
-
Patent number: 4128570Abstract: A method of treating mammals for allergy and anaphylactic reactions of a reagin or non-reagin mediated nature which comprises administering prophylactically to said mammal an anti-allergy or anaphylactic reaction effective amount of a compound of the formula ##STR1## Novel compounds and compositions are also claimed.Type: GrantFiled: October 6, 1977Date of Patent: December 5, 1978Assignee: The Upjohn CompanyInventors: Charles M. Hall, John B. Wright
-
Patent number: 4126617Abstract: Novel chemical compounds of the formula: ##STR1## wherein R is selected from the group consisting of hydrogen, alkyl from one to three carbon atoms, inclusive, phenyl, alkali metal, or an amine cation;X and Y can be the same or different and are selected from the group consisting of hydrogen, alkyl or from one to six carbon atoms, inclusive, cycloalkyl of 5 or 6 carbon atoms, inclusive, phenyl, hydroxyl, alkoxy having from one to three carbon atoms, inclusive, halogen, trifluoromethyl, cyano, carboxyamide and ##STR2## where Q is selected from the group consisting of hydrogen, alkyl from one to three carbon atoms, inclusive, alkali metal, and an amine cation, with the proviso that whereR is hydrogen, alkali metal or an amine cation, then Q is the same as R, and whereR is phenyl or alkyl from one to three carbon atoms, then Q is phenyl or alkyl from one to three carbon atoms; andZ is selected from the group consisting of hydrogen, alkyl from one to three carbon atoms, inclusive, and phenyl.Type: GrantFiled: August 5, 1976Date of Patent: November 21, 1978Assignee: The Upjohn CompanyInventors: Charles M. Hall, Herbert G. Johnson, John B. Wright
-
Patent number: 4119783Abstract: Pharmaceutical compositions having as the active agent a compound of the formula ##STR1## useful for preventing allergic manifestations in sensitized mammals and novel compounds.Type: GrantFiled: February 18, 1977Date of Patent: October 10, 1978Assignee: The Upjohn CompanyInventors: Charles M. Hall, John B. Wright
-
Patent number: 4113880Abstract: Novel compounds of the formula ##STR1## where R is hydrogen, a physiologically acceptable metal or amine cation, or alkyl of one to eight carbon atoms, inclusive, R.sub.1 is hydrogen, a physiologically acceptable metal or amine cation, or alkyl of one to eight carbon atoms, inclusive, are formulated into pharmaceutical compositions useful for preventing allergic manifestations in sensitized mammals.Type: GrantFiled: November 17, 1976Date of Patent: September 12, 1978Assignee: The Upjohn CompanyInventors: Charles M. Hall, John B. Wright
-
Patent number: 4095028Abstract: Compounds represented below ##STR1## and pharmaceutical compositions thereof, the compositions including the non-substituted phenylene dioxamates are useful in the prophylactic treatment of sensitized mammals for allergy and all anaphylactic reactions of a reagin or non-reagin mediated nature.Type: GrantFiled: August 16, 1976Date of Patent: June 13, 1978Assignee: The Upjohn CompanyInventors: Charles M. Hall, John B. Wright
-
Patent number: 4089973Abstract: Compounds represented below ##STR1## and pharmaceutical compositions thereof, the compositions including the non-substituted phenylene dioxamates are useful in the prophylactic treatment of sensitized mammals for allergy and all anaphylactic reactions of a reagin or non-reagin mediated nature.Type: GrantFiled: August 16, 1976Date of Patent: May 16, 1978Assignee: The Upjohn CompanyInventors: Charles M. Hall, John B. Wright